dc.contributor.author | Ribeiro, Neide F. | |
dc.contributor.author | Leal, Ernesto Cesar Pinto Jr | |
dc.contributor.author | Johnson, Douglas S. | |
dc.contributor.author | Demchak, Timothy | |
dc.contributor.author | Machado, Caroline M. | |
dc.contributor.author | Dias, Luana B. | |
dc.contributor.author | DE Oliveira, Marcelo F. | |
dc.contributor.author | Lino, Matheus M. | |
dc.contributor.author | Rodrigues, Wesley D. | |
dc.contributor.author | Santo, Jonathan | |
dc.contributor.author | DE Barros, Carolina N. | |
dc.contributor.author | Casalechi, Heliodora L. | |
dc.contributor.author | Da Silva Tomazoni, Shaiane | |
dc.date.accessioned | 2024-04-03T13:12:38Z | |
dc.date.available | 2024-04-03T13:12:38Z | |
dc.date.created | 2024-01-29T08:44:12Z | |
dc.date.issued | 2023 | |
dc.identifier.issn | 1973-9087 | |
dc.identifier.uri | https://hdl.handle.net/11250/3124697 | |
dc.description.abstract | BACKGROUND: Fibromyalgia is a syndrome characterized by generalized chronic pain and tenderness in specific areas. Photobiomodulation therapy (PBMT) using low-level laser therapy and/or light emitting diode therapy is an electrophysical agent that can be used alone or together with a static magnetic field (PBMT-sMF) to promote analgesia in several health conditions. Little evidence exists regarding the effects of using PBMT and PBMT-sMF in patients with fibromyalgia; this evidence is conflicting.
AIM: We aimed to investigate the effects of using PBMT-sMF versus a placebo on reduction of the degree-of-pain rating, impact of fibromyalgia, pain intensity, and satisfaction with treatment in patients with fibromyalgia.
DESIGN: A prospectively registered, monocentric, randomized placebo-controlled trial, with blinding of patients, therapists, and assessors, was performed.
SETTING: The study was conducted at the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil, between March and October 2020.
POPULATION: Ninety female patients with fibromyalgia were randomized to undergo either PBMT-sMF (N.=45) or placebo (N.=45) treatment.
METHODS: Patients from both groups received nine treatment sessions, three times a week, for 3 weeks. Clinical outcomes were collected at baseline, the end of treatment, and at the follow-up appointment 4 weeks post-treatment. The primary outcome was the degree-of-pain rating, measured by the reduction of the tender point count.
RESULTS: A decrease in the degree-of-pain rating was observed in patients allocated to the PBMT-sMF group, decreasing the number of tender points when compared to placebo group at the end of treatment (P<0.0001) and at the follow-up assessment (P<0.0001). Patients did not report any adverse events.
CONCLUSIONS: PBMT-sMF is superior to placebo, supporting its use in patients with fibromyalgia.
CLINICAL REHABILITATION IMPACT: PBMT-sMF might be considered an important adjuvant to the treatment regimens of patients with fibromyalgia. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Edizioni Minerva Medica | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no | * |
dc.title | Photobiomodulation therapy combined with static magnetic field is better than placebo in patients with fibromyalgia: a randomized placebo-controlled trial | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2023 The Author(s) | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | 10.23736/S1973-9087.23.07928-5 | |
dc.identifier.cristin | 2236414 | |
dc.source.journal | European Journal of Physical and Rehabilitation Medicine | en_US |
dc.source.pagenumber | 754-762 | en_US |
dc.identifier.citation | European Journal of Physical and Rehabilitation Medicine. 2023, 59 (6), 754-762. | en_US |
dc.source.volume | 59 | en_US |
dc.source.issue | 6 | en_US |